Because compounded products are customized for individual patients, they do not carry the same regulatory status or the same level of premarket evidence as branded products
The studies are small, but they suggest: More regular cycles Improved ovulation Better outcomes with IVF in some cases Importantly, the most recent data (2024) shows no increased risk of birth defects, miscarriage, or pregnancy complications with GLP-1 exposure
Several biological and behavioral factors influence how the body responds to GLP-1 medications: 1
Licensed 503A compounding follows strict FDA oversight and state pharmacy board regulations, ensuring sterility, potency, and safety identical to mass-manufactured drugs
Healthy aging support: MOTS-c has gained interest because mitochondrial function and metabolic signaling often decline with age
Serious reactions are uncommon but real, which is why both forms are prescription only and should be monitored